COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier

This is the first report of COVID‐19 in a human T‐cell lymphotropic virus type‐1 (HTLV‐1) carrier. HTLV‐1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID‐19‐HTLV‐1 coinfection, specifically on the appropriate use...

Descripción completa

Detalles Bibliográficos
Autores principales: Enomoto, Takatoshi, Shiroyama, Takayuki, Hirata, Haruhiko, Amiya, Saori, Adachi, Yuichi, Niitsu, Takayuki, Noda, Yoshimi, Hara, Reina, Fukushima, Kiyoharu, Suga, Yasuhiko, Miyake, Kotaro, Koyama, Shohei, Iwahori, Kota, Nagatomo, Izumi, Tokuhira, Natsuko, Uchiyama, Akinori, Takeda, Yoshito, Kumanogoh, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847415/
https://www.ncbi.nlm.nih.gov/pubmed/35223018
http://dx.doi.org/10.1002/ccr3.5463
_version_ 1784652045519683584
author Enomoto, Takatoshi
Shiroyama, Takayuki
Hirata, Haruhiko
Amiya, Saori
Adachi, Yuichi
Niitsu, Takayuki
Noda, Yoshimi
Hara, Reina
Fukushima, Kiyoharu
Suga, Yasuhiko
Miyake, Kotaro
Koyama, Shohei
Iwahori, Kota
Nagatomo, Izumi
Tokuhira, Natsuko
Uchiyama, Akinori
Takeda, Yoshito
Kumanogoh, Atsushi
author_facet Enomoto, Takatoshi
Shiroyama, Takayuki
Hirata, Haruhiko
Amiya, Saori
Adachi, Yuichi
Niitsu, Takayuki
Noda, Yoshimi
Hara, Reina
Fukushima, Kiyoharu
Suga, Yasuhiko
Miyake, Kotaro
Koyama, Shohei
Iwahori, Kota
Nagatomo, Izumi
Tokuhira, Natsuko
Uchiyama, Akinori
Takeda, Yoshito
Kumanogoh, Atsushi
author_sort Enomoto, Takatoshi
collection PubMed
description This is the first report of COVID‐19 in a human T‐cell lymphotropic virus type‐1 (HTLV‐1) carrier. HTLV‐1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID‐19‐HTLV‐1 coinfection, specifically on the appropriate use of corticosteroid treatment while considering secondary infection.
format Online
Article
Text
id pubmed-8847415
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88474152022-02-25 COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier Enomoto, Takatoshi Shiroyama, Takayuki Hirata, Haruhiko Amiya, Saori Adachi, Yuichi Niitsu, Takayuki Noda, Yoshimi Hara, Reina Fukushima, Kiyoharu Suga, Yasuhiko Miyake, Kotaro Koyama, Shohei Iwahori, Kota Nagatomo, Izumi Tokuhira, Natsuko Uchiyama, Akinori Takeda, Yoshito Kumanogoh, Atsushi Clin Case Rep Case Reports This is the first report of COVID‐19 in a human T‐cell lymphotropic virus type‐1 (HTLV‐1) carrier. HTLV‐1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID‐19‐HTLV‐1 coinfection, specifically on the appropriate use of corticosteroid treatment while considering secondary infection. John Wiley and Sons Inc. 2022-02-15 /pmc/articles/PMC8847415/ /pubmed/35223018 http://dx.doi.org/10.1002/ccr3.5463 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Enomoto, Takatoshi
Shiroyama, Takayuki
Hirata, Haruhiko
Amiya, Saori
Adachi, Yuichi
Niitsu, Takayuki
Noda, Yoshimi
Hara, Reina
Fukushima, Kiyoharu
Suga, Yasuhiko
Miyake, Kotaro
Koyama, Shohei
Iwahori, Kota
Nagatomo, Izumi
Tokuhira, Natsuko
Uchiyama, Akinori
Takeda, Yoshito
Kumanogoh, Atsushi
COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
title COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
title_full COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
title_fullStr COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
title_full_unstemmed COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
title_short COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
title_sort covid‐19 in a human t‐cell lymphotropic virus type‐1 carrier
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847415/
https://www.ncbi.nlm.nih.gov/pubmed/35223018
http://dx.doi.org/10.1002/ccr3.5463
work_keys_str_mv AT enomototakatoshi covid19inahumantcelllymphotropicvirustype1carrier
AT shiroyamatakayuki covid19inahumantcelllymphotropicvirustype1carrier
AT hirataharuhiko covid19inahumantcelllymphotropicvirustype1carrier
AT amiyasaori covid19inahumantcelllymphotropicvirustype1carrier
AT adachiyuichi covid19inahumantcelllymphotropicvirustype1carrier
AT niitsutakayuki covid19inahumantcelllymphotropicvirustype1carrier
AT nodayoshimi covid19inahumantcelllymphotropicvirustype1carrier
AT harareina covid19inahumantcelllymphotropicvirustype1carrier
AT fukushimakiyoharu covid19inahumantcelllymphotropicvirustype1carrier
AT sugayasuhiko covid19inahumantcelllymphotropicvirustype1carrier
AT miyakekotaro covid19inahumantcelllymphotropicvirustype1carrier
AT koyamashohei covid19inahumantcelllymphotropicvirustype1carrier
AT iwahorikota covid19inahumantcelllymphotropicvirustype1carrier
AT nagatomoizumi covid19inahumantcelllymphotropicvirustype1carrier
AT tokuhiranatsuko covid19inahumantcelllymphotropicvirustype1carrier
AT uchiyamaakinori covid19inahumantcelllymphotropicvirustype1carrier
AT takedayoshito covid19inahumantcelllymphotropicvirustype1carrier
AT kumanogohatsushi covid19inahumantcelllymphotropicvirustype1carrier

Ejemplares similares